# Marker Therapeutics (MRKR) — Earnings

MRKR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mrkr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.12 |
| EPS estimate | −$0.36 |
| EPS surprise | +66.67% |
| Revenue surprise | +70.53% |
| Revenue | $1.2M |
| Revenue estimate | $723,000.00 |
| Reported | Nov 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1094038/000110465925111502/mrkr-20250930x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 13, 2025 | −$0.36 | −$0.12 | 66.67% | $723,000.00 | $1.2M |
| Q2 2025 | Aug 14, 2025 | −$0.30 | −$0.25 | 17.74% | $430,600.00 | $880,600.00 |
| Q1 2025 | May 15, 2025 | −$0.53 | −$0.40 | 24.56% | $174,550.00 | $349,104.00 |
| Q4 2024 | Mar 31, 2025 | −$0.22 | −$0.41 | -86.36% | $1.2M | $2.3M |
| Q3 2024 | Nov 14, 2024 | −$0.39 | −$0.26 | 33.33% | $1.0M | $1.9M |
| Q2 2024 | Aug 14, 2024 | −$0.43 | −$0.25 | 41.98% | — | $1.2M |
| Q1 2024 | May 15, 2024 | −$0.25 | −$0.27 | -8.00% | — | $1.2M |
| Q4 2023 | Mar 26, 2024 | −$0.90 | $0.44 | 148.89% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.90 | −$0.34 | 62.22% | — | $257,606.00 |
| Q2 2023 | Aug 14, 2023 | −$0.80 | $0.29 | 136.25% | — | $762,658.00 |
| Q4 2022 | Mar 22, 2023 | −$1.00 | −$0.48 | 52.00% | — | $3.3M |
| Q3 2022 | Nov 10, 2022 | −$1.30 | −$0.80 | 38.46% | $400,000.00 | $3.9M |
| Q2 2022 | Aug 11, 2022 | −$1.05 | −$1.10 | -4.76% | $2.5M | $790,508.00 |
| Q1 2022 | May 13, 2022 | −$1.20 | −$1.20 | 0.00% | $1.0M | $964,322.00 |
| Q4 2021 | Mar 17, 2022 | −$1.28 | −$1.10 | 13.73% | — | $1.2M |
| Q3 2021 | Nov 10, 2021 | −$1.28 | −$1.50 | -17.65% | — | — |
| Q2 2021 | Aug 10, 2021 | −$1.18 | −$1.30 | -10.64% | — | — |
| Q1 2021 | May 12, 2021 | −$1.45 | −$1.60 | -10.34% | — | — |
| Q4 2020 | Mar 9, 2021 | −$1.60 | −$1.70 | -6.25% | — | — |
| Q3 2020 | Nov 9, 2020 | −$1.45 | −$1.60 | -10.34% | — | — |

## Frequently Asked Questions

### When did Marker Therapeutics (MRKR) last report earnings?

Marker Therapeutics last reported on Nov 13, 2025, covering fiscal Q3 2025.

### Did MRKR beat earnings estimates?

Yes. Marker Therapeutics reported EPS of −$0.12 for Q3 2025 against a −$0.36 estimate — a 66.67% beat.

### How much revenue did MRKR report last quarter?

Marker Therapeutics reported $1.2M in revenue for Q3 2025, against a consensus estimate of $723,000.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).